Asthma in smokers: Challenges and opportunities

Current Opinion in Pulmonary Medicine

Volumn 15, Issue 1, 2009, Pages 39-45

  Thomson, Neil C ^a   Chaudhuri, Rekha ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Airway inflammation; Asthma; Combination therapy; Corticosteroid insensitivity; Corticosteroids; Leukotriene receptor antagonists; Smokers; Smoking cessation; Theophyllines

Indexed keywords

BECLOMETASONE; BUDESONIDE; CHLOROFLUOROCARBON; CORTICOSTEROID; FLUTICASONE; GLUCOCORTICOID RECEPTOR; HISTAMINE; HISTONE DEACETYLASE; MONTELUKAST; SALMETEROL;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SENSITIVITY; ENZYME ACTIVITY; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LOW DRUG DOSE; MONOTHERAPY; PATHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; LEUKOTRIENE ANTAGONISTS; SEVERITY OF ILLNESS INDEX; SMOKING; TREATMENT OUTCOME;

EID: 58149214006     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32831da894     Document Type: Review

References (75)

1. CDC. Fact Sheet: Adult cigarette smoking in the United States: current estimates. Smoking and Tobacco Use; 2006. http://www.cdc.gov/tobacco/data- statistics/Factsheets/adult-cig-smoking.html.
2. The European Tobacco Control Report; 2007. http://wwweurowhoint/document/ e89842pdf.
3. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004;24:822-833.
4. Yun S, Chanetsa F, Kelsey A, et al. Active and passive smoking among asthmatic Missourians: implications for health education. Prevent Med 2006; 42:286-290.
5. Silverman RA, Boudreaux ED, Woodruff PG, et al. Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest 2003; 123:1472-1479.
6. Tyc VL, Throckmorton-Belzer L. Smoking rates and the state of smoking interventions for children and adolescents with chronic illness. Pediatrics 2006; 118:e471-e487.
7. Schatz M, Zeiger RS, Vollmer WM, et al. Determinants of future long-term asthma control. J Allergy Clin Immunol 2006; 118:1048-1053.
8. McCoy K, Shade DM, Irvin CG, et al. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol 2006; 118:1226-1233.
9. Strine TW, Balluz LS, Ford ES. The associations between smoking, physical inactivity, obesity, and asthma severity in the general US population. J Asthma 2007; 44:651-658. Large telephone survey undertaken in 50 states in the United States of over 11 000 individuals with asthma found that current smokers compared with nonsmokers reported increased asthma attacks and more visits to the emergency room for asthma.
10. Leuppi JD, Steurer-Stey C, Peter M, et al. Asthma control in Switzerland: a general practitioner based survey. Curr Med Res Opin 2006; 22:2159-2166.
11. Chapman KR, Boulet LP, Rea RM, et al. Suboptimal asthma control: pre- valence, detection and consequences in general practice. Eur Respir J 2008; 31:320-325. A useful survey by Canadian general practitioners of asthma control in the community, demonstrating that smoking is a significant factor associated with poor symptom control.
12. Laforest L, Van Ganse E, Devouassoux G, et al. Influence of patients' characteristics and disease management on asthma control. J Allergy Clin Immunol 2006; 117:1404-1410.
13. Chaudhuri R, McSharry C, McCoard A, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 2008; 63:132-135. The study shows that all symptoms of asthma control, assessed by the Juniper Asthma Control Questionnaire score, are worse in smokers despite having similar lung function.
14. Eisner MD, Iribarren C. The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res 2007; 9:53-56. A prospective study of 865 participants with asthma in the United States demonstrating that smoking worsens asthma-specific quality of life scores and increases healthcare utilization.
15. Sippel JM, Pedula KL, Vollmer WM, et al. Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest 1999; 115:691-696.
16. Siroux V, Pin I, Oryszcyn MP, et al. Relationships of active smoking to asthma and asthma severity in the EGEA study. Eur Respir J 2000; 15:470-477.
17. Stallberg B, Lisspers K, Hasselgren M, et al. Factors related to the level of severity of asthma in primary care. Respir Med 2007; 101:2076-2083.
18. Adams RJ, Weiss ST, Fuhlbrigge A. How and by whom care is delivered influences anti-inflammatory use in asthma: results of a national population survey. J Allergy Clin Immunol 2003; 112:445-450.
19. Marks G, Burney P, Premaratne U, et al. Asthma in Greenwich, UK: impact of the disease and current management practices. Eur Respir J 1997; 10:1224-1229.
20. Radeos M, Leak L, Hanrahan J, et al. Risk factors for lack of asthma selfmanagement knowledge among ED patients not on inhaled steroids. Am J Emerg Med 2001; 19:253-259.
21. Janson C, de Marco R, Accordini S, et al. Changes in the use of antiasthmatic medication in an international cohort. Eur Respir J 2005; 26:1047-1055.
22. Abdulwadud O, Abramson M, Forbes A, et al. Attendance at an asthma educational intervention: characteristics of participants and nonparticipants. Respir Med 1997;91:524-529.
23. Yoon R, McKenzie D, Miles D, et al. Characteristics of attenders and nonattenders at an asthma education programme. Thorax 1991; 46:886-890.
24. Gallefoss F, Bakke P, Wang I, et al. Smoking status, disease duration, and educational level in females, are related to asthma school participation. Eur Respir J 2000; 15:1022-1025.
25. Lange P, Pamer J, Vestbo J, et al. A 15 year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-1200.
26. Apostol G, Jacobs D, Tsai A, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40. Am J Respir Crit Care Med 2002; 166:166-172.
27. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005; 171:109-114.
28. Lee JH, Haselkorn T, Borish L, et al. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest 2007; 132:1882-1889.
29. Marquette C, Saulnier F, Leroy O, et al. Long-term prognosis of near-fatal asthma. Am Rev Respir Dis 1992; 146:76-81.
30. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1075 outpatients with asthma. Chest 1995; 108:10-15.
31. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57:226-230.
32. Tomlinson JEM, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus nonsmokers with mild asthma. Thorax 2005; 60:282-287.
33. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175:783-790. Placebo-controlled, crossover study in asthmatic smokers and nonsmokers confirming the poor response of asthmatic smokers to inhaled corticosteroids and demonstrating a beneficial effect of leukotriene antagonists in these patients.
34. Pedersen SE, Bateman ED, Bousquet J, et al. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma control study. J Allergy Clin Immunol 2007; 120:1036-1042. An interesting post-hoc analysis of the results of the GOAL study that examined the influence of smoking status on the response to inhaled fluticasone or combined fluticasone/salmeterol treatment over a year. Asthma exacerbation rates were increased in smokers with asthma receiving inhaled fluticasone compared with never smokers with asthma and, in the smoking group, exacerbation rates were reduced with combination therapy compared with inhaled fluticasone alone.
35. Lange P, Scharling H, Ulrik CS, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006; 61:100-104.
36. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006; 61:105-110.
37. Pedersen B, Dahl R, Karlstrom R, et al. Eosinophil and neutrophil activity in asthma in one-year trial with inhaled budesonide. Am J Respir Crit Care Med 1996; 153:1519-1529.
38. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168:1308-1311.
39. Livingston E, Chaudhuri R, McMahon AD, et al. Systemic sensitivity to corticosteroids in smokers with asthma. Eur Respir J 2007; 29:64-71. Study measuring cutaneous vasoconstrictor test response to corticosteroids as a test of corticosteroid resistance, showing that reduced responsiveness to corticosteroids in smokers may extend beyond the airways.
40. Jang A-S, Lee J-H, Park SW, et al. Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma. Chest 2005; 128:1140-1145.
41. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007; 119:1043-1052.
42. Chalmers G, MacLeod K, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120:1917-1922.
43. Boulet L-P, Lemiere C, Archambault F, et al. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 2006; 129:661-668.
44. + mature dendritic cells in the large airway of smokers compared with nonsmokers, which the authors speculate may contribute to the increased frequency of lower respiratory tract infections in smokers with asthma.
45. Bergeron C, Boulet L-P, Page N, et al. Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J Allergy Clin Immunol 2007; 119:391-397.
46. Carroll N, Perry S, Karkhanis A, et al. The airway longitudinal elastic fiber network and mucosal folding in patients with asthma. Am J Respir Crit Care Med 2000; 161:244-248.
47. Livingston E, Darroch C, Chaudhuri R, et al. Glucocorticoid receptor alpha to beta ratio in blood mononuclear cells is reduced in cigarette smokers. J Allergy Clin Immunol 2004; 114:1475-1478.
48. Lewis-Tuffin LJ, Cidlowski JA. The physiology of human glucocorticoid receptor S (hGRβ) and glucocorticoid resistance. Ann N Y Acad Sci 2006; 1069:1-9.
49. Leung D, Bloom J. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003; 111:3-22.
50. Barnes PJ. Corticosteroid resistance in airway disease. Proc Am Thorac Soc 2004; 1:264-268.
51. Ito K, Lim S, Caramori G, et al. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 15: 1110-1112.
52. Cosio BG, Mann B, Ito K, et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood monocytes in asthma. Am J Respir Crit Care Med 2004; 170:141-147.
53. Cosio BG, Tsaprouni L, Ito K, et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004; 200:689-695.
54. 99mTc-DTPA in asthma. Am Rev Respir Dis 1988; 139:1139-1143.
55. Kennedy S, Elwood R, Wiggs B, et al. Increased airway mucosal permeability of smokers: relationship to airway reactivity. Am Rev Respir Dis 1984; 129:143-148.
56. Cerveri I, Accordini S, Corsico A, et al. Chronic cough and phlegm in young adults. Eur Respir J 2003; 22:413-417.
57. Invernizzi G, Ruprecht A, Paredi P, et al. Particle size of dry powder fluticasone is modified in the presence of tobacco smoke. Eur Respir J 2004; 34 (Suppl 48):28s.
58. Lynch D, Newell J, Tschomper B, et al. Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993; 188:829-833.
59. Mitsunobu F, Ashida K, Hosaki Y, et al. Influence of long-term cigarette smoking on immunoglobin E-mediated allergy, pulmonary function, highresolution computed tomography lung densitometry in elderly patients with asthma. Clin Exp Allergy 2004; 34:59-64.
60. Thomson NC. Smokers with asthma: what are the management options? Am J Respir Crit Care Med 2007; 175:749-750. A brief summary of the status of treatment of smokers with asthma and in particular the possible role of leukotriene-receptor antagonists.
61. Travers J, Marsh S, Williams M, et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 2007; 62:219-223.
62. Suzuki K, Tanaka H, Kaneko S, et al. Respiratory symptoms and cigarette smoking in 3197 pulmonologist-based asthmatic patients with a highly prevalent use of inhaled corticosteroid. J Asthma 2003; 40:243-250.
63. Tonnesen P, Pisinger C, Hvidberg S, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res 2005; 7:139-148.
64. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174:127-133.
65. Eisner M, Yelin E, Katz P, et al. Predictors of cigarette smoking and smoking cessation among adults with asthma. Am J Public Health 2000; 90:1307-1311.
66. Wakefield M, Ruffin R, Campbell D, et al. Smoking-related beliefs and behaviour among adults with asthma in a representative population sample. Aust N ZJ Med 1995; 25:12-17.
67. Jimenez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119:1365-1370.
68. Braganza G, Chaudhuri R, Thomson NC. Review: treating patients with respiratory disease who smoke. Ther Adv Respir Dis 2008; 2:95-107. Comprehensive review of effects of smoking on drugs used to treat respiratory diseases including asthma.
69. GINA Report, Global Strategy for Asthma Management and Prevention; 2006. http://wwwginasthmacom/Guideline.
70. Montelukast Asthmatic Smoker Study. 2006. http://www.clinicaltrials.gov/ ct/show/NCT00284856?order=6.
71. Magnussen H, Bugnas B, van Noord J, et al. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med 2008; 102:50-56.
72. Le Houezec J. Why a nicotine vaccine? Clin Pharmacol Ther 2005; 78:453-455.
73. Tonnesen P, Carrozzi L, Fagerstrom KO, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007; 29:390-417. Useful evidence-based review of smoking cessation techniques recommended by a European Respiratory Society task force.
74. Barnes PJ, Stockley RA. COPD: current therapeutic interventions and future approaches. Eur Respir J 2005; 25:1084-1106.
75. Barnes PJ, Ito K, Adcock IM. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 2004; 363:731-733.